Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-14

Clinical Trial Update: Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children [NA]

View source ↗

Summary

Clinical trial comparing aripiprazole to placebo for reducing aggressive and aberrant behavior in autistic children; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Autism | NA | Status: COMPLETED | Results posted: 2022-01-14